Literature DB >> 22720303

"Red flag" evaluation yield in irritable bowel syndrome.

Tyler P Black1, Catherine S Manolakis, Jack A Di Palma.   

Abstract

BACKGROUND: The diagnosis of irritable bowel syndrome (IBS) is based on clinical criteria. Further diagnostic testing is advised for certain "red flag" alarm or warning signs. AIM: This investigation was designed to examine the yield of testing for "red flags".
METHODS: Consecutive patients who were prospectively evaluated and met the ROME III criteria for IBS were reviewed for "red flags" which included: 1) rectal bleeding, 2) iron-deficiency anemia (IDA), 3) weight loss, 4) family history of colon cancer, 5) fever, and 6) age of onset after age 50. The evaluations were reviewed for type of testing and findings. Subjects with nocturnal symptoms and fecal soiling, although not traditional warning signs, were also reviewed.
RESULTS: There were 200 patients who met the IBS criteria; 139 (70%) had a "red flag" alarm symptom or sign. Diarrhea predominant-IBS (D-IBS) was seen in 105, constipation predominant-IBS (C-IBS) in 57, alternating, mixed, or pain predominant-IBS in 38. There were 30 men and 170 women. Testing was not often performed in this setting and, when done, the yield was low with few clinically significant diagnostic findings.
CONCLUSION: There was a high prevalence of "red flag" symptoms or signs in the prospectively evaluated IBS cohort, but a low frequency of diagnostic testing directed at the investigation of these symptoms or signs. Further systematic study may show that the yield for testing in IBS is low even when "red flags" prompt diagnostic testing.

Entities:  

Mesh:

Year:  2012        PMID: 22720303

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  14 in total

Review 1.  Pathophysiology and management of opioid-induced constipation: European expert consensus statement.

Authors:  Adam D Farmer; Asbjørn M Drewes; Giuseppe Chiarioni; Roberto De Giorgio; Tony O'Brien; Bart Morlion; Jan Tack
Journal:  United European Gastroenterol J       Date:  2018-12-14       Impact factor: 4.623

2.  Sleep Disturbances Are Commonly Reported Among Patients Presenting to a Gastroenterology Clinic.

Authors:  Sarah Ballou; Eaman Alhassan; Elise Hon; Cara Lembo; Vikram Rangan; Prashant Singh; William Hirsch; Thomas Sommers; Johanna Iturrino; Judy Nee; Anthony Lembo
Journal:  Dig Dis Sci       Date:  2018-08-09       Impact factor: 3.199

3.  Effectiveness of Anise Oil for Treatment of Mild to Moderate Depression in Patients With Irritable Bowel Syndrome: A Randomized Active and Placebo-Controlled Clinical Trial.

Authors:  Maryam Mosaffa-Jahromi; Ali-Mohammad Tamaddon; Suleiman Afsharypuor; Alireza Salehi; Seyed Hassan Seradj; Mehdi Pasalar; Peyman Jafari; Kamran Bagheri Lankarani
Journal:  J Evid Based Complementary Altern Med       Date:  2016-02-11

4.  Cost Effectiveness of Biomarker Tests for Irritable Bowel Syndrome With Diarrhea: A Framework for Payers.

Authors:  Christopher V Almario; Benjamin D Noah; Alma Jusufagic; Daniel Lew; Brennan M R Spiegel
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-27       Impact factor: 11.382

5.  Do Socio-Demographics Play a Role in the Prevalence of Red Flags and Pursuant Colonoscopies in Patients With Irritable Bowel Syndrome?

Authors:  Anmol Mittal; Shivani Gupta; Faiz Afridi; Anthony Dimitrey; Sushil Ahlawat
Journal:  Cureus       Date:  2022-05-19

6.  Rome III survey of irritable bowel syndrome among ethnic Malays.

Authors:  Yeong Yeh Lee; Anuar Waid; Huck Joo Tan; Andrew Seng Boon Chua; William E Whitehead
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

Review 7.  Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview.

Authors:  Theodor Bokic; Martin Storr; Rudolf Schicho
Journal:  Pharmacology       Date:  2015-07-01       Impact factor: 2.547

Review 8.  Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.

Authors:  Roberto De Giorgio; Furio Massimino Zucco; Giuseppe Chiarioni; Sebastiano Mercadante; Enrico Stefano Corazziari; Augusto Caraceni; Patrizio Odetti; Raffaele Giusti; Franco Marinangeli; Carmine Pinto
Journal:  Adv Ther       Date:  2021-06-04       Impact factor: 3.845

9.  A Rome III survey of functional dyspepsia among the ethnic Malays in a primary care setting.

Authors:  Yeong Yeh Lee; Noriza Wahab; Nazri Mustaffa; Norwati Daud; Noorhayati Mohd Noor; Juwita Shaaban; Andrew Seng Boon Chua
Journal:  BMC Gastroenterol       Date:  2013-05-14       Impact factor: 3.067

Review 10.  The epidemiology of irritable bowel syndrome.

Authors:  Caroline Canavan; Joe West; Timothy Card
Journal:  Clin Epidemiol       Date:  2014-02-04       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.